Nasopharyngeal carcinoma epidemiology and demographics: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Nasopharyngeal carcinoma}} | {{Nasopharyngeal carcinoma}} | ||
{{CMG}} | {{CMG}} |
Revision as of 17:21, 17 August 2015
Nasopharyngeal carcinoma Microchapters |
Differentiating Nasopharyngeal carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Nasopharyngeal carcinoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Nasopharyngeal carcinoma epidemiology and demographics |
FDA on Nasopharyngeal carcinoma epidemiology and demographics |
CDC on Nasopharyngeal carcinoma epidemiology and demographics |
Nasopharyngeal carcinoma epidemiology and demographics in the news |
Blogs on Nasopharyngeal carcinoma epidemiology and demographics |
Risk calculators and risk factors for Nasopharyngeal carcinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology
Age
While NPC is seen primarily in middle-aged persons in Asia, a high proportion of African cases appear in children.
Demographics
NPC is uncommon in the United States and most other nations, but is extremely common in Taiwan and certain regions of China, accounting for 18% of all cancers in the latter nation. The cause of increased risk for NPC in these endemic regions is not entirely clear.[1]
References
- ↑ Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor). Modern Surgical Pathology (2 Volume Set). London: W B Saunders. ISBN 0-7216-7253-1.